NanoXplore Announces Appointment of New Board Member

NanoXplore Inc. ("NanoXplore" or the "Corporation") ( TSX: GRA and OTCQX: NNXPF ), a world-leading graphene company, announces the nomination of Ms. Catherine Loubier to its Board of Directors.

The nomination of Ms. Loubier followed an extensive search process by the Corporate Governance and Nominating Committee of the Board. The Board will continue to ensure its composition is well aligned to support senior management with the execution of its new five-year strategic growth plan and with the next phase of the Company's growth.

Ms. Loubier brings significant experience and expertise to complement the capabilities of the Board, and drive shareholder value.

"I'm pleased to announce the nomination of Catherine to the Board. With her skillsets in corporate governance and leadership, she is well positioned to provide the effective oversight and direction required for NanoXplore's ambitious vision, plan, and purpose and I am confident that her presence will strengthen the ability to execute our mandate of value creation for all shareholders." said Benoît Gascon, Lead Director of the Board.

Ms. Catherine Loubier is a senior advisor to the corporate world. In her recent role as Quebec's Delegate General in New York, from February 2019 to August 2021, she was instrumental in finalizing the largest renewable hydropower contract ever with New York State. She previously served as Deputy Chief of Staff to the Premier of Quebec from October 2018 to February 2019. From 2015 to 2018, she advised business leaders in various industries, including the President and CEO of Alliance Renault Nissan Mitsubishi. She spent nearly ten years in the federal government, including as senior adviser to the 22nd Prime Minister of Canada from 2013 to 2015 and a member of the senior staff of federal ministers from 2006. She is a member of the Women's Forum New York and a board member of administration of the Canadian American Business Council and the Council for Canadian American Relations. Ms. Loubier holds a bachelor's and master's degree from the University of Quebec in Montreal, obtained in 1996, and a certificate from Harvard Business School, obtained in 2020

About NanoXplore

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities in Canada, the United States and Europe.

For further information, please contact:

Martin Gagné
Director of Investor Relations
martin.gagne@nanoxplore.ca
Tel: 438.476.1342


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF
The Conversation (0)
Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Contract manufacturing services as a new business line has the potential to generate approximately $4-5 million in annual revenues First manufacturing services contract signed with Secretome Therapeutics Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company... Keep Reading...
Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the "Research Group"). This study aims to evaluate the efficacy of Sona's Targeted... Keep Reading...
Why Invest in Nanotech Stocks?

Why Invest in Nanotech Stocks?

The nanotechnology market is experiencing a promising stage of growth, making it an attractive space for investors.From nanotech-based solar panels that increase energy efficiency to pharmaceutical products that make use of nanotech in drug-delivery systems, nanotechnology has far-reaching... Keep Reading...

SILO Pharma Inc

SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. Keep Reading...
Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this... Keep Reading...
Vaxcyte Inc.

Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Keep Reading...

Interactive Chart

Latest Press Releases

Related News